Fig. 7From: Combating drug resistance in acute myeloid leukaemia by drug rotations: the effects of quizartinib and pexidartinibCell counts and growth rates for cells treated with pexidartinib at IC90 (PE*) at generations 1 and 4 and quizartinib at IC50 (QI) at generations 2, 3, 5, and 6. The growth rates (divisions per cell and day), were calculated at days 3 and 6, and are indicated on each line. a MOLM-14 cells, b MV4-11 cellsBack to article page